These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35032694)

  • 21. Inherited and acquired determinants of serum tryptase levels in humans.
    Lyons JJ
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):420-426. PubMed ID: 34175497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
    Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker.
    O'Connell MP; Lyons JJ
    Curr Opin Allergy Clin Immunol; 2022 Apr; 22(2):143-152. PubMed ID: 35197435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
    Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O
    J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: are we there yet?
    Couto ML; Silva M; Barbosa MJ; Ferreira F; Fragoso AS; Azenha Rama T
    Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):152-160. PubMed ID: 36927821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardized indolent systemic mastocytosis evaluations across a health care system: implications for screening accuracy.
    McMurray JC; Pacheco CS; Schornack BJ; Sun X; Brunader JA; Scott AE; Ariza JS; Kou CJ; Costantino RC; Pittman LM; Adams KE; Waters AM; Pryor EM; Lyons JJ; Metcalfe DD; Maric I; Boggs NA
    Blood; 2024 Jul; 144(4):408-419. PubMed ID: 38635793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia.
    O'Connell MP; Lyons JJ
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):431-437. PubMed ID: 32769710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
    Polivka L; Madrange M; Bulai-Livideanu C; Barete S; Ballul T; Neuraz A; Greco C; Agopian J; Brenet F; Dubreuil P; Burdet C; Lemal R; Tournilhac O; Terriou L; Launay D; Bouillet L; Gourguechon C; Damaj G; Frenzel L; Meni C; Bouktit H; Collange AF; Gaudy-Marqueste C; Gousseff M; Le Mouel E; Hamidou M; Neel A; Ranta D; Jaussaud R; Guilpain P; Canioni D; Molina TJ; Bruneau J; Lhermitte L; Garcelon N; Javier RM; Pelletier F; Castelain F; Retornaz F; Cabrera Q; Zunic P; Gourin MP; Wierzbicka-Hainaut E; Viallard JF; Lavigne C; Hoarau C; Durieu I; Heiblig M; Dimicoli-Salazar S; Torregrosa-Diaz JM; Soria A; Arock M; Lortholary O; Bodemer C; Hermine O; Rossignol J;
    J Allergy Clin Immunol; 2024 Jan; 153(1):349-353.e4. PubMed ID: 37633651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome.
    Hamilton MJ; Zhao M; Giannetti MP; Weller E; Hufdhi R; Novak P; Mendoza-Alvarez LB; Hornick J; Lyons JJ; Glover SC; Castells MC; Pozdnyakova O
    Am J Surg Pathol; 2021 Jul; 45(7):997-1004. PubMed ID: 33481382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase.
    Fellinger C; Hemmer W; Wöhrl S; Sesztak-Greinecker G; Jarisch R; Wantke F
    Allergol Immunopathol (Madr); 2014; 42(6):544-52. PubMed ID: 25224360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Report: A family history of peanut allergy and hereditary alpha-tryptasemia.
    Chantran Y; Renaudin H; Arock M; Guiddir T; Nemni A
    Front Allergy; 2023; 4():1322117. PubMed ID: 38327735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serum tryptase test: an emerging robust biomarker in clinical hematology.
    Valent P; Sperr WR; Sotlar K; Reiter A; Akin C; Gotlib J; Horny HP; Arock M
    Expert Rev Hematol; 2014 Oct; 7(5):683-90. PubMed ID: 25169217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders.
    Vazquez M; Chovanec J; Kim J; DiMaggio T; Milner JD; Francomano CA; Gurnett CA; Ritelli M; Colombi M; Lyons JJ
    HGG Adv; 2022 Apr; 3(2):100094. PubMed ID: 35287299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy.
    Novak P; Giannetti MP; Weller E; Hamilton MJ; Castells M
    Ann Allergy Asthma Immunol; 2022 Mar; 128(3):299-306.e1. PubMed ID: 34648976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology.
    Sperr WR; El-Samahi A; Kundi M; Girschikofsky M; Winkler S; Lutz D; Endler G; Rumpold H; Agis H; Sillaber C; Jäger U; Valent P
    Eur J Clin Invest; 2009 Oct; 39(10):914-23. PubMed ID: 19522836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Curious Case of Elevated Tryptase: Workup and Differential in Family of Four.
    Cochran AL; Coop C; Neaves BI; Wood ST
    Cureus; 2023 Apr; 15(4):e38065. PubMed ID: 37228529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.
    Valent P; Bonadonna P; Hartmann K; Broesby-Olsen S; Brockow K; Butterfield JH; Triggiani M; Lyons JJ; Oude Elberink JNG; Arock M; Metcalfe DD; Akin C
    Int Arch Allergy Immunol; 2019; 180(1):44-51. PubMed ID: 31256161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal.
    Tanasi I; Crosera L; Taus F; Orsolini G; Adami G; Olivieri F; Bernardelli A; Bonadonna P; Nalin F; Sella S; Giannini S; Liu Y; Mannelli F; Vanderwert F; Bonifacio M; Krampera M; Rossini M; Lyons JJ; Zanotti R
    Bone; 2024 Sep; 186():117141. PubMed ID: 38823568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast Cell Disorders and Hymenoptera Venom-Triggered Anaphylaxis: Evaluation and Management.
    Boggs NA; Tanasi I; Hartmann K; Zanotti R; Gonzalez-de-Olano D
    J Allergy Clin Immunol Pract; 2024 Aug; ():. PubMed ID: 39187156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.